These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 19515537
1. In vitro analyses of the combination of high-dose doxycycline and antifungal agents against Candida albicans biofilms. Miceli MH, Bernardo SM, Lee SA. Int J Antimicrob Agents; 2009 Oct; 34(4):326-32. PubMed ID: 19515537 [Abstract] [Full Text] [Related]
3. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm. Pesee S, Angkananuwat C, Tancharoensukjit S, Muanmai S, Sirivan P, Bubphawas M, Tanarerkchai N. Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371 [Abstract] [Full Text] [Related]
4. In vitro evaluation of antibiotic lock technique for the treatment of Candida albicans, C. glabrata, and C. tropicalis biofilms. Ko KS, Lee JY, Song JH, Peck KR. J Korean Med Sci; 2010 Dec; 25(12):1722-6. PubMed ID: 21165285 [Abstract] [Full Text] [Related]
5. Effects of fluconazole, amphotericin B, and caspofungin on Candida albicans biofilms under conditions of flow and on biofilm dispersion. Uppuluri P, Srinivasan A, Ramasubramanian A, Lopez-Ribot JL. Antimicrob Agents Chemother; 2011 Jul; 55(7):3591-3. PubMed ID: 21518839 [Abstract] [Full Text] [Related]
7. Interaction of Candida albicans biofilms with antifungals: transcriptional response and binding of antifungals to beta-glucans. Vediyappan G, Rossignol T, d'Enfert C. Antimicrob Agents Chemother; 2010 May; 54(5):2096-111. PubMed ID: 20194705 [Abstract] [Full Text] [Related]
8. In vitro activity of antifungal combinations against Candida albicans biofilms. Tobudic S, Kratzer C, Lassnigg A, Graninger W, Presterl E. J Antimicrob Chemother; 2010 Feb; 65(2):271-4. PubMed ID: 19996142 [Abstract] [Full Text] [Related]
9. Quinacrine inhibits Candida albicans growth and filamentation at neutral pH. Kulkarny VV, Chavez-Dozal A, Rane HS, Jahng M, Bernardo SM, Parra KJ, Lee SA. Antimicrob Agents Chemother; 2014 Dec; 58(12):7501-9. PubMed ID: 25288082 [Abstract] [Full Text] [Related]
10. Repurposing as a means to increase the activity of amphotericin B and caspofungin against Candida albicans biofilms. Delattin N, De Brucker K, Vandamme K, Meert E, Marchand A, Chaltin P, Cammue BP, Thevissen K. J Antimicrob Chemother; 2014 Apr; 69(4):1035-44. PubMed ID: 24284780 [Abstract] [Full Text] [Related]
14. Antifungal activity of amphotericin B, caspofungin and posaconazole on Candida albicans biofilms in intermediate and mature development phases. Tobudic S, Lassnigg A, Kratzer C, Graninger W, Presterl E. Mycoses; 2010 May; 53(3):208-14. PubMed ID: 19298353 [Abstract] [Full Text] [Related]
15. Susceptibility of Candida albicans biofilms to azithromycin, tigecycline and vancomycin and the interaction between tigecycline and antifungals. Ku TS, Palanisamy SK, Lee SA. Int J Antimicrob Agents; 2010 Nov; 36(5):441-6. PubMed ID: 20685088 [Abstract] [Full Text] [Related]
19. Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. Louie A, Kaw P, Banerjee P, Liu W, Chen G, Miller MH. Antimicrob Agents Chemother; 2001 Feb; 45(2):485-94. PubMed ID: 11158745 [Abstract] [Full Text] [Related]
20. Paradoxical antifungal activity and structural observations in biofilms formed by echinocandin-resistant Candida albicans clinical isolates. Walraven CJ, Bernardo SM, Wiederhold NP, Lee SA. Med Mycol; 2014 Feb; 52(2):131-139. PubMed ID: 24576999 [Abstract] [Full Text] [Related] Page: [Next] [New Search]